Home > Balance Sheet > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹4.47 Cr₹3.48 Cr₹6.71 Cr₹16 Cr₹1.69 Cr

What is the latest Capital Work in Progress ratio of LINCOLN PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of LINCOLN PHARMACEUTICALS is ₹4.47 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹4.47 Cr
Mar2024₹3.48 Cr
Mar2023₹6.71 Cr
Mar2022₹16 Cr
Mar2021₹1.69 Cr

How is Capital Work in Progress of LINCOLN PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹4.47 Cr
28.34
Mar2024 ₹3.48 Cr
-48.12
Mar2023 ₹6.71 Cr
-58.18
Mar2022 ₹16 Cr
852.19
Mar2021 ₹1.69 Cr -

Compare Capital Work in Progress of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,152.2 Cr 0.4% -6.4% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

0.4%

-6.4%

-4.7%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses